TABLE 9

Ligand-binding affinities for approved and investigational SRIF ligands

	SST₁	SST₂	SST₃	SST₄	SST₅
Octreotide^{^a}	>1000	0.4	4.4	>1000	5.6
Lanreotide^{^b}	2129	0.75	98	1826	5.2
Pasireotide^{^c}	9.3	1	1.5	>100	0.16
Veldoreotide^{^d}	>1000	3	>100	7	6

↵^a Data from Reisine and Bell (1995), Patel (1999).
↵^b Data from Shimon et al. (1997b), Zatelli et al. (2001).
↵^c Data from Bruns et al. (2002).
↵^d Data from Afargan et al. (2001).